Get started
Precision BioSciences, Inc.Precision BioSciences, Inc.Precision BioSciences, Inc.

Precision BioSciences, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

DTIL chart


Full chart

DTIL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪34.52 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
88.06
Basic EPS (TTM)
0.08 USD
Net income (FY)
‪−69.77 M‬ USD
Revenue (FY)
‪48.73 M‬ USD
Shares float
‪3.73 M‬
Beta (1Y)
1.49

Employees


Employees (FY)
109
Change (1Y)
−89 −44.95%
Revenue / Employee (1Y)
‪447.04 K‬ USD
Net income / Employee (1Y)
‪−390.16 K‬ USD

About Precision BioSciences, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Michael Amoroso
Website
precisionbiosciences.com
Headquarters
Durham
Founded
2006
FIGI
BBG008NSBPV3
Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

DTIL news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where DTIL is featured.

See all sparks 

Frequently Asked Questions


The current price of DTIL is 4.50 USD — it hasn't changed in the past 24 hours. Watch Precision BioSciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Precision BioSciences, Inc. stocks are traded under the ticker DTIL.
DTIL stock has fallen by −3.23% compared to the previous week, the month change is a −30.88% fall, over the last year Precision BioSciences, Inc. has showed a −58.33% decrease.
We've gathered analysts' opinions on Precision BioSciences, Inc. future price: according to them, DTIL price has a max estimate of 60.00 USD and a min estimate of 19.00 USD. Watch DTIL chart and read a more detailed Precision BioSciences, Inc. stock forecast: see what analysts think of Precision BioSciences, Inc. and suggest that you do with its stocks.
DTIL reached its all-time high on Dec 9, 2019 with the price of 710.11 USD, and its all-time low was 4.13 USD and was reached on Dec 18, 2024. View more price dynamics on DTIL chart.
See other stocks reaching their highest and lowest prices.
DTIL stock is 4.61% volatile and has beta coefficient of 1.49. Track Precision BioSciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Precision BioSciences, Inc. there?
Today Precision BioSciences, Inc. has the market capitalization of ‪18.29 M‬, it has decreased by −1.75% over the last week.
Yes, you can track Precision BioSciences, Inc. financials in yearly and quarterly reports right on TradingView.
Precision BioSciences, Inc. is going to release the next earnings report on Mar 18, 2025. Keep track of upcoming events with our Earnings Calendar.
DTIL earnings for the last quarter are −2.25 USD per share, whereas the estimation was −2.14 USD resulting in a −5.34% surprise. The estimated earnings for the next quarter are −2.25 USD per share. See more details about Precision BioSciences, Inc. earnings.
Precision BioSciences, Inc. revenue for the last quarter amounts to ‪576.00 K‬ USD, despite the estimated figure of ‪5.33 M‬ USD. In the next quarter, revenue is expected to reach ‪4.28 M‬ USD.
DTIL net income for the last quarter is ‪−16.43 M‬ USD, while the quarter before that showed ‪32.75 M‬ USD of net income which accounts for −150.15% change. Track more Precision BioSciences, Inc. financial stats to get the full picture.
No, DTIL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 109.00 employees. See our rating of the largest employees — is Precision BioSciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Precision BioSciences, Inc. EBITDA is ‪−10.83 M‬ USD, and current EBITDA margin is −72.82%. See more stats in Precision BioSciences, Inc. financial statements.
Like other stocks, DTIL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Precision BioSciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Precision BioSciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Precision BioSciences, Inc. stock shows the sell signal. See more of Precision BioSciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.